Profile data is unavailable for this security.
About the company
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
- Revenue in USD (TTM)17.32m
- Net income in USD-17.10m
- Incorporated2020
- Employees109.00
- LocationVivos Therapeutics Inc7921 Southpark Plaza,, Suite 210LITTLETON 80120United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://vivos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeartSciences Inc | 8.67k | -9.04m | 9.53m | 15.00 | -- | 2.20 | -- | 1,099.73 | -6.95 | -6.95 | 0.0057 | 1.36 | 0.0013 | 0.0056 | -- | 578.00 | -131.22 | -145.78 | -202.97 | -316.21 | 57.90 | 56.93 | -104,225.80 | -42,610.78 | 2.00 | -10.00 | 0.1068 | -- | -76.61 | -41.63 | -32.70 | -- | 21.46 | -- |
| Movano Inc | 500.00k | -17.05m | 9.83m | 32.00 | -- | -- | -- | 19.65 | -6.54 | -6.54 | 0.0883 | -2.04 | 0.0485 | 0.8216 | 3.51 | 15,625.00 | -165.32 | -159.40 | -360.23 | -208.33 | -270.20 | -- | -3,409.60 | -11,662.69 | 0.3451 | -12.46 | 2.32 | -- | -- | -- | 18.97 | -- | -9.25 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 9.88m | 9.00 | -- | -- | -- | 6.14 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| BioRegenx Inc | 1.93m | -18.93m | 10.00m | 5.00 | -- | -- | -- | 5.19 | -0.0195 | -0.0195 | 0.002 | -0.0038 | 0.2083 | 3.15 | 47.03 | 385,874.00 | -204.29 | -- | -341.72 | -- | 78.14 | -- | -980.96 | -- | 0.0416 | -8.01 | -- | -- | -31.40 | -- | -540.38 | -- | -- | -- |
| PAVmed Inc | 29.00k | -595.00k | 10.40m | 39.00 | 28.24 | 28.50 | -- | 358.78 | -0.6822 | -0.6822 | 0.0005 | 1.55 | 0.0009 | -- | 3.05 | 743.59 | 4.17 | -115.64 | 8.14 | -8,726.29 | -520.69 | -- | 4,931.04 | -3,891.34 | -- | -- | 0.2111 | -- | 22.15 | -- | 148.24 | -- | 15.12 | -- |
| QHSLab Inc | 2.61m | -386.75k | 10.85m | 4.00 | -- | -- | -- | 4.15 | -0.0373 | -0.0373 | 0.1997 | -0.0542 | 1.49 | 26.38 | 12.80 | 653,480.00 | -22.10 | -39.97 | -- | -284.79 | 66.37 | 55.22 | -14.80 | -44.62 | 0.1714 | 0.3038 | 1.63 | -- | 51.31 | -- | 44.65 | -- | -- | -- |
| Beyond Air Inc | 5.80m | -36.70m | 11.06m | 61.00 | -- | 0.6605 | -- | 1.91 | -7.54 | -7.54 | 1.15 | 1.59 | 0.1382 | 2.60 | 8.01 | 95,114.76 | -89.86 | -81.28 | -105.60 | -103.40 | -6.70 | -- | -650.33 | -4,167.72 | 3.73 | -16.50 | 0.4351 | -- | 219.67 | 21.66 | 22.60 | -- | 166.66 | -- |
| REMSleep Holdings Inc | 12.27k | -3.01m | 11.15m | 6.00 | -- | 46.21 | -- | 908.37 | -0.0019 | -0.0019 | 0.00001 | 0.0002 | 0.0193 | 0.825 | 1.51 | -- | -472.04 | -107.16 | -671.87 | -177.21 | 94.87 | -- | -24,509.54 | -1,456.22 | 1.73 | -- | 0.2146 | -- | -42.47 | -- | 39.36 | -- | 5.18 | -- |
| BioNano Genomics Inc | 28.72m | -38.59m | 11.19m | 98.00 | -- | 0.2149 | -- | 0.3898 | -737.92 | -737.92 | 9.99 | 5.12 | 0.3451 | 1.45 | 5.84 | 293,061.20 | -46.37 | -58.31 | -69.84 | -72.53 | 45.97 | 18.60 | -134.36 | -487.42 | 1.82 | -- | 0.07 | -- | -14.79 | 24.89 | 51.82 | -- | 11.02 | -- |
| SINTX Technologies Inc | 1.27m | -16.56m | 11.69m | 20.00 | -- | 2.70 | -- | 9.21 | -6.93 | -6.93 | 0.5894 | 1.13 | 0.1121 | 1.34 | 5.52 | 63,500.00 | -86.86 | -51.41 | -121.23 | -64.34 | 52.05 | 66.36 | -775.12 | -575.95 | 1.60 | -302.73 | 0.0143 | -- | 9.90 | 33.18 | -33.06 | -- | 36.24 | -- |
| Vicarious Surgical Inc | 0.00 | -53.59m | 12.95m | 123.00 | -- | 0.7699 | -- | -- | -9.04 | -9.04 | 0.00 | 2.36 | 0.00 | -- | -- | 0.00 | -97.47 | -35.33 | -109.17 | -37.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.04 | -- | -6.06 | -- |
| Trinity Biotech PLC (ADR) | 49.41m | -35.91m | 14.22m | 401.00 | -- | -- | -- | 0.2878 | -2.19 | -2.22 | 3.19 | -2.57 | 0.5094 | 1.52 | 3.48 | 123,217.00 | -37.02 | -23.08 | -52.54 | -35.97 | 33.81 | 38.51 | -72.67 | -32.84 | 0.4083 | -1.73 | 1.79 | -- | 8.31 | -7.41 | 15.33 | -- | -3.22 | -- |
| Vivos Therapeutics Inc | 17.32m | -17.10m | 14.35m | 109.00 | -- | 4.96 | -- | 0.8284 | -1.88 | -1.88 | 1.93 | 0.3063 | 0.8449 | -- | 13.38 | 158,871.60 | -83.45 | -85.27 | -120.33 | -138.51 | 55.74 | 67.27 | -98.77 | -108.16 | -- | -- | 0.7785 | -- | 8.91 | 5.70 | 18.02 | -- | 26.46 | -- |
| Phaos Technlgy Hldngs (Cayman) Limited | 132.98k | -100.00bn | 14.53m | -- | -- | -- | -- | 109.26 | -- | -- | -- | -0.0605 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.3176 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| United Health Products Inc | 0.00 | -2.95m | 16.43m | 10.00 | -- | -- | -- | -- | -0.0116 | -0.0116 | 0.00 | -0.0129 | 0.00 | -- | -- | 0.00 | -2,405.94 | -4,956.01 | -- | -- | -- | -- | -- | -137,625.90 | -- | -16.29 | -- | -- | -- | -- | 23.69 | -- | -- | -- |
| Envoy Medical Inc | 208.00k | -28.61m | 17.27m | 42.00 | -- | -- | -- | 83.04 | -1.44 | -1.44 | 0.0103 | -0.3218 | 0.0237 | 0.50 | 1.79 | 4,952.38 | -247.90 | -- | -- | -- | -294.23 | -- | -10,475.00 | -- | 0.4582 | -14.86 | -- | -- | -28.80 | -- | 10.55 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Vivos Therapeutics Inc's reporting currency: US Dollar USD
8.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 273.33k | 2.90% |
| Connective Capital Management LLCas of 30 Sep 2025 | 200.00k | 2.12% |
| DRW Securities LLCas of 31 Dec 2025 | 115.91k | 1.23% |
| Geode Capital Management LLCas of 31 Dec 2025 | 56.29k | 0.60% |
| B. Riley Wealth Advisors, Inc.as of 30 Sep 2025 | 43.53k | 0.46% |
| Commonwealth Equity Services LLCas of 31 Dec 2025 | 40.50k | 0.43% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 30.83k | 0.33% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 27.82k | 0.30% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 24.92k | 0.26% |
| Acorn Wealth Advisors LLCas of 31 Dec 2025 | 14.78k | 0.16% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
